Although we do not know the mechanisms underlying the H3K27me3 HIST1high signature, this focal high level of H3K27me3 may reflect a maintained activity of EZH2 previously shown to be associated with favorable outcome in AML [24]. This evidence concerns the gene EZH2 and acute myeloid leukemia.